Ajooni Biotech share price & results
- Jun 2026
- Aug 2026
Punjab-based PURE VEG. compounded cattle-feed and feed-supplement manufacturer supplying dairies, cooperatives and farmers across India.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 63.5 | +103.0% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | 2.6 | +0.4 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | 0.43 | −44.9% YoY | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. |
| Return on equity | 4.42 | +1.4 pts | Trailing twelve months | TTM to Jun 2026 | Adjusted profit attributable to owners ÷ average owners’ equity. |
| Free cash flow margin | -12.55 | +16.2 pts | Fiscal year | FY ending Mar 2026 | (Operating cash flow − fixed-asset purchases + disposals) ÷ revenue. |
| Revenue growth (YoY) | 78.40 | +14.5 pts | Trailing twelve months | TTM to Jun 2026 | Revenue change against the same period one year earlier. |
Price
Performance −43.7% 1Y
1Y: ₹5.13 on 24 Oct 2025 → ₹2.89. High ₹5.2 (29 Oct 2025), low ₹2.87 (21 Oct 2026).
- Previous close
- ₹2.87
- Market cap
- ₹52 Cr
- 52-week range
- ₹2.87 – ₹5.2
- One year
- −43.88%
- Price to earnings (TTM to Jun 2026)
- 13.13×
- Return on equity (TTM to Jun 2026)
- 4.42%
Overview
- Symbol
- NSE:AJOONI
- Exchange
- NSE
- Currency
- INR
What Ajooni Biotech Limited does
Based on the company's own presentations, annual report and earnings calls.
Ajooni Biotech makes vegetarian (no animal by-product) compounded cattle feed, cattle feed chips, camel feed, cotton oil cake and mustard oil cake, plus a range of feed supplements (mineral mixtures, tonics, digestive powders, multivitamins) at its GMP-certified plant in Khanna, Punjab. It sells mainly to large institutional dairy and milk-processing clients such as Mother Dairy, Paras Dairy, Saahaj Dairy, Banas Dairy and National Dairy Services, while also building out a direct dealer/distributor network to reach farmers, and exports to Nepal, Bangladesh and Sri Lanka.
Segments
- Feed & Others
- Supplements
- Manufacturing units
- 3
- PURE VEG. animal feed installed capacity
- 57,000 MTPA (further 70,000 MTPA expansion in process)
- Dry powder supplement capacity
- 3,000 MTPA
- Liquid supplement capacity
- 55 lakh litres
- Warehouse size
- 40,000 sq ft
- Dealer/distributor network
- 150+ (FY25)
Fundamentals
Ratios, each with its period
Current values with the period they cover; the trend reads across the 6 fiscal years held (Mar 2021 to Mar 2026).
Financials
What the filings say
Net profit, year on year: −45% (quarter to jun 2026 against jun 2025).
| Line item | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 26 | 34 | 29 | 31 | 32 | 59 | 61 | 63 |
| Expenses | 25 | 33 | 28 | 31 | 30 | 56 | 60 | 62 |
| Operating profit | 1 | 1 | 1 | 1 | 2 | 3 | 1 | 2 |
| Operating margin | 3.0% | 2.7% | 3.5% | 2.3% | 4.7% | 5.2% | 1.7% | 2.6% |
| Other income | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
| Profit before tax | 1 | 1 | 2 | 1 | 1 | 2 | 1 | 1 |
| Tax rate | 22.8% | 27.7% | 19.4% | 24.3% | 24.4% | 30.1% | 15.2% | 34.9% |
| Net profit | 1 | 1 | 2 | 1 | 1 | 2 | 1 | 0 |
| EPS (₹ per share) | 0.04 | 0.04 | 0.09 | 0.05 | 0.05 | 0.10 | 0.06 | 0.02 |
| Line item | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| Sales | 80 | 115 | 182 |
| Expenses | 78 | 111 | 176 |
| Operating profit | 2 | 4 | 6 |
| Other income | 2 | 2 | 2 |
| Interest | 1 | 0 | 1 |
| Depreciation | 1 | 1 | 2 |
| Profit before tax | 3 | 4 | 6 |
| Net profit | 2 | 3 | 4 |
| Line item | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sept 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Equity capital | 10 | 18 | 18 | 34 | 34 | 34 |
| Reserves | 6 | 24 | 25 | 54 | 55 | 57 |
| Borrowings | 5 | 5 | 2 | 2 | 9 | 18 |
| Other liabilities | 7 | 12 | 3 | 5 | 5 | 11 |
| Total liabilities | 29 | 59 | 48 | 95 | 104 | 120 |
| Fixed assets | 6 | 6 | 10 | 11 | 11 | 26 |
| Capital work in progress | 0 | 0 | 1 | 0 | 11 | 0 |
| Investments | 1 | 4 | 2 | 3 | 3 | 2 |
| Other assets | 22 | 48 | 34 | 80 | 78 | 92 |
| Total assets | 29 | 59 | 48 | 95 | 104 | 120 |
| Line item | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Cash from operations | 1 | 4 | -6 | 23 | -32 | -6 |
| Cash from investing | -3 | -2 | -16 | 8 | 14 | -16 |
| Cash from financing | 2 | -2 | 22 | -4 | 25 | 15 |
| Net cash flow | 0 | 0 | 0 | 27 | 6 | -6 |
| Free cash flow | -2 | 2 | -8 | 17 | -33 | -23 |
| Line item | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Debtor days | 98 | 68 | 101 | 59 | 52 | 36 |
| Inventory days | 46 | 34 | 39 | 80 | 90 | 97 |
| Days payable | 46 | 39 | 56 | 8 | 13 | 22 |
| Cash conversion cycle | 98 | 63 | 83 | 131 | 129 | 111 |
| Working capital days | 77 | 58 | 94 | 132 | 158 | 93 |
| Return on capital employed | 5.0% | 9.0% | 6.0% | 8.0% | 5.0% | 6.0% |
| Dividend payout | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
What the price assumes
AttractiveTo justify its price of ₹3, this stock must grow earnings at 12% every year for 7 years. Our analysis caps realistic growth at ~145%. At that growth it is worth ₹507 — upside of 17450%.
- Growth the price implies
- 12.2% a year
- for 7 years, fading to 4%
- It has actually compounded at
- 94.8% a year
- net profit, FY24–FY26 · EPS 144.9%
- The gap
- -1.3 pp
- 17450% downside if it only repeats history
Ownership
Who owns it
Public hold 69.47% as of Aug 2026; institutions added 0.00 pts since Jun 2026.
- Promoters 30.53%
- Foreign institutions 0.00%
- Domestic institutions 0.00%
- Public 69.47%
Who bought this quarter
since Jun 2026
Disclosed holders that added to a position or appeared on the register for the first time, biggest addition first.
- newly disclosed 4.97% held
The same filing shows 5 holders trimming and 0 off the list — both are in the register beside this.
Who is on the register
Named in the Aug 2026 filing
Every holder of Ajooni Biotech Limited above SEBI's 1% disclosure line, and what changed since Jun 2026.
| Holder | Stake | Change |
|---|---|---|
| 15.98% | −0.84 pp | |
| 4.97% | newly disclosed | |
| 4.30% | −0.22 pp | |
| 2.42% | −0.12 pp | |
| 1.81% | −0.09 pp | |
| 1.75% | −0.10 pp | |
| 1.11% | unchanged |
A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.
Your own record
Start an Inve Case for Ajooni Biotech Limited
Free account: one company. Everything above stays public.
Write why you follow Ajooni Biotech Limited and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading
Other Fast Moving Consumer Goods companies
- NG
NGILNakoda Group of Industries Limited - AL
ALCODISAlcokraft Distilleries Limited - AG
AGRITECHAgri-Tech (India) Limited - SP
SPRIGHTSPRIGHT AGRO LIMITED - SU
SUNDARAMSundaram Multi Pap Limited - WA
WARRENTEAWarren Tea Ltd. - PR
PRUDMOULIPrudential Sugar Corporation Limited - DA
DANGEEDangee Dums Limited
Learn to analyse Ajooni Biotech Limited
Guides on how to read this kind of business and the numbers that matter.